Simon Arkell OLY

Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound. Our technology empowers clinicians to make precise, efficient, and accurate assessments, drawing from the largest known heart disease dataset in echocardiography. We target challenging cardiac diseases, starting with HFpEF, to support timely diagnosis and early intervention. In collaboration with the Mayo Clinic, Johnson & Johnson, and Pfizer, we are continuously developing innovative diagnostic tools aimed at halting the progression of heart failure. Learn more: https://www.ultromics.com/. Follow Ultromics on social media for the latest news, X: https://x.com/ultromics, LinkedIn: https://www.linkedin.com/company/ultromics/.

UneeQ is an intelligent AI interface company, developing the most advanced autonomous digital human platform available for customer interactions – today and in tomorrow’s metaverse. Our mission is to deliver digital human experiences that excel in marketing, sales and service roles – reducing complexity, improving conversions and creating memorable customer moments for brands. Find out more at digitalhumans.com

Virtue is a new venture firm backing radical founders at the earliest stage determined to transform our broken healthcare system.

Ryght’s powerful, global site network of AI Site Twins transforms how sponsors manage site selection and feasibility. Our digital replicas of every research site worldwide enable data-driven decisions that reduce costs and compress timelines.

Neu Health is making the latest Parkinsons disease and dementia care accessible for all through an innovative, smartphone-based clinical platform and patient programme. We are a spinout from the University of Oxford that builds on 10 years of research and clinical validation.

SIERRA Ventures is an early-stage venture firm investing in the future of Enterprise and Emerging Technologies. With over four decades of experience and over $2 billion of assets under management, Sierra has created a vast network of successful entrepreneurs, Fortune 1000 CXOs, operational executives, and deep domain experts, providing a platform for entrepreneurs worldwide. For more information visit the Sierra Ventures website at https://www.sierraventures.com Twitter: @Sierra_Ventures

With unparalleled networks and decades of sector experience, we chart the course alongside early-stage founders in B2B healthcare. We specialize in three distinct areas within B2B healthcare where our impact is proven and tangible. 1. Decentralized Care: Shifting patient care from high-cost specialist settings to alternative, more accessible primary care and home environments. 2. Economics of Care: Developing more transparent and efficient payment systems and data exchanges, including implementing alternative reimbursement models. 3. Healthcare Supply Chain: Improving the healthcare supply chain by harnessing innovative solutions to address the industrys most pressing inefficiencies. Tamarind Hill was founded by a team of entrepreneurs, investors, and operators with a long history of value creation in healthcare. Our funds invest in early stage, tech-driven, healthcare companies that have found early product-market fit, and can benefit from our operating expertise and capital to fully prove out their model and make the jump to high-growth recurring revenue software businesses. We bring a private equity mindset to to early stage investing, we use our earned perspective and operator-first mentality to guide our founders through their own unique journeys to scale. We believe that every one of our entrepreneurs can have a successful outcome.